Rethinking rituximab in neuroimmunology: Real-world efficacy, cost-effectiveness, and long-term remission
Real-World Efficacy of Rituximab Rituximab, a monoclonal antibody targeting CD20, is primarily known for its use in certain hematological malignancies […]

